Wales Health, Biotech & Nutrition R&D Companies Directory

Aberystwyth University is a leading Welsh research institution that leverages deep expertise in plant science, microbiology, and food technology to drive innovation in the UK agri-tech and nutrition sectors. Their work spans the development of functional foods, sustainable agricultural practices, and advanced diagnostic tools for crop and environmental health. Through extensive collaborative R&D, they bridge the gap between fundamental academic research and commercial application, focusing on improving food security, reducing environmental impacts, and enhancing public health.

ReNeuron is a UK regenerative medicine company developing stem cell therapies for degenerative diseases, including stroke, limb ischaemia, retinitis pigmentosa, and glioblastoma. Their technology spans human neural stem cell lines, exosomes, and retinal progenitor cells, with a focus on industrialising manufacturing processes to commercialise cell therapies. Their grant history shows progression from clinical trials to scalable manufacturing platforms.

Germinal Holdings Limited is a plant breeding and forage science company that develops high-performance crop varieties to improve agricultural sustainability and livestock production efficiency. Their work focuses on enhancing nutrient use efficiency and yield resilience in forage grasses and legumes, transitioning from traditional livestock feed to sustainable plant-based protein sources. Through extensive academic and industry partnerships, they integrate genomic selection and advanced phenotyping to address the environmental challenges of modern agriculture.

TrakCel provides software solutions for the cell and gene therapy supply chain, including chain of identity and chain of custody tracking. Their technology facilitates the safe and efficient delivery of advanced therapy medicinal products (ATMPs) from manufacturer to patient. Through involvement in the UK's Advanced Therapy Treatment Centre network, they have focused on automating logistics, manufacturing processes, and standardising tissue collection protocols.

Agroceutical Products is a Welsh farmer-led organisation that develops sustainable agricultural technologies, specialising in the extraction and application of plant-based compounds (alkaloids) from daffodils and other natural sources for nutraceutical, pharmaceutical, and agricultural uses. Their work has evolved from regulatory compliance for galanthamine production to developing feed efficiency solutions for dairy cattle, sustainable biolubricants from wool, and controlled environment agriculture for medicine production.

Bionema Group is a Swansea-based biological crop protection and plant health solutions provider. The company develops innovative products such as microencapsulated fungal biopesticides, biofilm-based fertilisers, and systemic biological molluscicides, aiming to reduce reliance on synthetic chemicals in agriculture. Their R&D has evolved from targeted pest control to integrated soil and crop health solutions, addressing challenges like pesticide resistance and nutrient management.

ImmunoServ specialises in developing T cell immunity tests for infectious diseases, having created a combined T cell and antibody capillary blood test for SARS-CoV-2 immunity screening. The company is now adapting its platform to create a standardised T cell immunity test for Group A Streptococcus, aiming to support vaccine development and population immunity monitoring. Its work is evolving from COVID-19 to other pathogens, leveraging a novel capillary blood testing approach.

Tendertec develops AI-powered home sensors for social care, focusing on fall detection, activity monitoring, and fitness engagement for older adults and underrepresented groups. Their work evolved from a large-scale project to promote physical activity among inactive older adults to a user-centred investigation of sensor repairability and sustainability.

Corryn Biotechnologies is a Welsh micro-enterprise developing advanced wound care technologies, including a resorbable wound dressing platform and an infection-detecting dressing. Their work targets chronic wounds, such as venous leg ulcers and diabetic foot ulcers, aiming to reduce healing times, prevent infections, and eliminate painful dressing changes.

Awen Oncology (also known as Ceridwen Oncology) is a Welsh spin-out from Bangor and Cardiff Universities, dedicated to developing novel cancer therapeutics. The company exploits previously unknown vulnerabilities in cancer cells to design selective drugs, using cost-effective compound screening methods. Their work aims to address the global challenge of cancer by creating breakthrough treatments for paediatric and adult cancers.

CatSci is a technology company specialising in sustainable pharmaceutical manufacturing. Initially focused on industrial biotechnology using enzymes (ketoreductases) for greener synthesis of active pharmaceutical ingredients, it has evolved to integrate computer vision, machine learning, and data analytics for process automation in medicines manufacturing. Their work addresses inefficiencies and errors in laboratory and scale-up processes, aiming to improve reproducibility, reduce waste, and enhance supply chain robustness.

MedaPhor develops augmented reality and deep learning technologies to assist clinicians in ultrasound-guided needling procedures. Their single grant focuses on creating a holographic overlay to improve needle placement accuracy and safety.

Biocatalysts Limited is a medium-sized enzyme manufacturer based in Cardiff, Wales, specialising in the development and production of high-value enzymes for the pharmaceutical, food, and industrial biotechnology sectors. Using microbial fermentation and recombinant DNA technology, the company has focused on creating broad-host expression systems and metagenomics platforms to efficiently discover and produce novel enzymes. Their grant history shows a progression from fundamental enzyme expression platforms to optimised yeast manufacturing processes, with significant collaborations with academic institutions such as EMBL-EBI and University College London.

Cell Mogrify is a micro-sized biotechnology company that uses data-driven bioinformatic tools to develop methods for generating any human cell type, aiming to accelerate the development of regenerative cell therapies. Their work focuses on reducing the time and cost of producing safe and scalable cell sources for therapeutic applications.

MeOmics Precision Medicine develops human cellular models to screen drug candidates for severe mental illnesses like schizophrenia, aiming to reduce the high cost and failure rates of clinical trials in psychiatry.

VRGO develops smart sensor technology to monitor and improve posture and movement, particularly for office workers to counter sedentary lifestyles and low back pain. Their fYt system uses multimodal pressure and motion sensing with haptic feedback and machine learning to provide personalised posture insights. The company evolved from a feasibility study to a collaborative R&D project focused on healthy ageing, building a service wrapper around their sensor prototype.

Indoor Biotechnologies is a micro/small enterprise based in Wales that develops cellular immunity tests, specifically T-cell response assays for monitoring immunity to infectious diseases like SARS-CoV-2. The company evolved from a feasibility study for a simple cellular immunity test to a larger SBRI-funded project developing a whole-blood T-cell test for assessing natural and vaccine-induced immune responses.

Conwy Kombucha is a Welsh micro-brewer of kombucha that has expanded into functional food research and waste valorisation. They explore converting kombucha production waste into organic fertilisers, study the cognitive and metabolic health benefits of fermented foods, and develop smart packaging (QR codes, smart jars) for home fermentation. Their work increasingly involves academic and industry consortia, targeting health, agriculture, and food technology sectors.

Signum Health develops a remote monitoring service for heart failure patients using text messaging and symptom tracking to reduce hospital admissions. Their system, built around the Flo interactive texting service and iNavigation care coordination tool, allows patients to report symptoms via their own phones, enabling early intervention by care coordinators. Their grant history shows a progression from an NHS Test Bed project to a COVID-19 feasibility study.

Davlec is a micro/small enterprise based in Wales that develops automated diagnostic systems for the dairy industry, focusing on milk sampling and reproduction testing. Their technology includes lateral flow readers and automated sampling devices to improve herd fertility and reduce calving intervals. Evolving from collaborative R&D to leading feasibility studies, they aim to commercialise cost-effective diagnostic tools for both agricultural and home testing markets.